Carbapenem-resistant Enterobacteriaceae, a group of highly resistant Gram-negative bacteria, have emerged as formidable pathogens in healthcare settings worldwide. Their resistance mechanisms render many first-line antibiotics ineffective, leading to limited treatment options and elevated mortality risks. Pediatric liver transplant recipients are particularly susceptible due to their immunocompromised state and frequent exposure to invasive procedures and broad-spectrum antibiotics. Thus, rapidly identifying those at greatest risk for CRE infections becomes a critical aspect of clinical management and outcomes improvement.

Wang and colleagues’ response emphasizes the nuanced role of predictive analytics in this context. They robustly defend their original methodology, which integrated clinical, microbiological, and biochemical parameters to anticipate the emergence of CRE infections post-transplantation. This multifactorial model incorporates variables such as prior antibiotic exposure, underlying comorbidities, organ function measures, and colonization status with CRE. Their meticulous approach highlights the importance of combining diverse data streams into a cohesive predictive algorithm, rather than relying on singular clinical indicators.

Central to their argument is the dynamic nature of microbial ecology within the hospital environment and the interplay between host factors and microbial virulence. The authors elucidate how shifts in bacterial populations within the gut microbiome of pediatric recipients, often exacerbated by prolonged antibiotic use, facilitate the selection and proliferation of carbapenem-resistant strains. They note that predictive models must adapt to these evolving microbial landscapes to maintain accuracy and clinical relevance, urging continuous dataset updates and regional customization.

Technological advances in machine learning and artificial intelligence are focal points in the response. Wang et al. detail how leveraging sophisticated computational techniques enables the handling of complex, high-dimensional data while uncovering subtle interactions between variables that traditional statistical methods might miss. Their model employs ensemble learning strategies that improve prediction robustness and mitigate overfitting—common pitfalls that compromise clinical utility. The response calls for broader adoption of these technologies to foster real-time risk stratification in transplant centers.

Furthermore, the team discusses challenges in external validation of predictive models across different healthcare settings. Variability in patient demographics, antibiotic stewardship policies, and infection control practices can significantly influence model performance. They advocate for multicenter collaborations to pool data and assess generalizability, warning against the uncritical application of models developed in single institutions. This collaborative vision aims to harmonize efforts and accelerate the integration of predictive tools into everyday clinical workflows.

An insightful exploration of immunological factors follows, illustrating how modulation of immune responses post-transplantation impacts susceptibility to CRE. The authors dissect the dual-edged sword of immunosuppressive regimens, which are vital to prevent organ rejection but simultaneously diminish host defenses. They propose that incorporating biomarkers of immune function into prediction algorithms could refine risk assessments and guide personalized antimicrobial prophylaxis.

The response also revisits the importance of early and accurate CRE detection. Wang et al. describe advances in rapid molecular diagnostics that complement predictive modeling by confirming colonization or infection status. PCR-based assays and next-generation sequencing offer unprecedented sensitivity and turnaround times, enabling prompt initiation of targeted therapies. They advocate for integrating diagnostic results into predictive platforms to create closed-loop clinical decision support systems.

In addressing critiques, the authors thoughtfully clarify misconceptions around statistical measures used to evaluate their model, such as the area under the receiver operating characteristics curve (AUC-ROC) and calibration metrics. They reinforce the robustness of their findings by demonstrating consistent performance in internal validation cohorts and highlighting strategies to mitigate bias and confounding. This transparency fosters confidence in the scientific rigor underpinning their work.

One particularly compelling section focuses on the ethical dimension of predictive analytics in pediatric care. Balancing the urgency of protecting immunocompromised children with the risks of overtreatment or unnecessary isolation requires careful ethical considerations. The authors advocate for integrating patient and family perspectives into risk communication and management decisions, thereby aligning technology-driven insights with compassionate care.

The response concludes with a forward-looking perspective on therapeutics. Recognizing the limited antibiotic arsenal against CRE, the authors discuss emerging adjunctive therapies, including bacteriophage therapy, novel β-lactamase inhibitors, and immunomodulatory agents. They posit that predictive models could pinpoint candidates for such therapies early in the disease course, potentially transforming outcomes and curbing resistance spread.

Wang et al. call for sustained investment in research to refine predictive analytics, enhance diagnostic capabilities, and expand antimicrobial options. Their comprehensive reply not only answers earlier critiques but also galvanizes the scientific and clinical communities toward a future where precision medicine defeats one of the most daunting challenges in pediatric liver transplantation. The integration of data science, microbiology, and clinical expertise stands poised to redefine infection control paradigms and safeguard the most vulnerable.

This articulate and multifaceted discussion resonates far beyond the niche of pediatric transplantation. It epitomizes how modern medicine increasingly relies on interdisciplinary collaboration, cutting-edge technology, and thoughtful ethical reflection to confront complex healthcare dilemmas. The implications of this research ripple across infectious disease management, antimicrobial stewardship, and health system strategies globally. As the scientific community embraces these innovations, the prospect of outmaneuvering multidrug-resistant superbugs like carbapenem-resistant Enterobacteriaceae becomes increasingly attainable.

In an era where antimicrobial resistance threatens global health, the insights shared by Wang YY, Wang WL, Sun Y, and their team represent a beacon of hope. Their dedication to refining precision prediction tools and fostering dialogue exemplifies progress in translational medicine. For pediatric liver transplant recipients, who already navigate a precarious clinical journey, such advancements herald safer, more individualized care pathways. The ripple effects of this work will undoubtedly influence policy, research funding priorities, and clinical protocols in the years to come.

Moving forward, the convergence of big data analytics, molecular diagnostics, and novel therapeutics will shape the next chapter in tackling carbapenem-resistant infections. Wang and colleagues’ response serves as a foundational piece, charting a course for collaborative innovation and a renewed commitment to overcome one of modern medicine’s most formidable adversaries. Their insights affirm that through science, technology, and compassion, the tide against antibiotic resistance can indeed be turned.

Subject of Research: Prediction of carbapenem-resistant Enterobacteriaceae infections in pediatric liver transplant recipients

Article Title: Response to: Comments on “Predicting carbapenem-resistant Enterobacteriaceae infections in pediatric liver transplant recipients”

Article References:
Wang, YY., Wang, WL., Sun, Y. et al. Response to: Comments on “Predicting carbapenem-resistant Enterobacteriaceae infections in pediatric liver transplant recipients”. World J Pediatr (2025). https://doi.org/10.1007/s12519-025-01006-1

Image Credits: AI Generated

DOI: 09 December 2025

The study evaluated over half a million pediatric visits across 843 diverse U.S. primary care sites, spanning family and pediatric medicine practices. By meticulously analyzing electronic health records from 2023, the researchers focused on episodes of ARTI care, comparing initial telehealth (TM) visits and traditional in-person (IP) consultations. Their retrospective cross-sectional analysis identified a striking 12% reduction in antibiotic prescriptions during telehealth visits, suggesting that virtual care modalities may contribute to more prudent antibiotic stewardship without compromising guideline adherence.

Antibiotic overuse has long been a critical issue, especially in pediatrics, where inappropriate prescribing for viral respiratory infections contributes to the global threat of antimicrobial resistance. Previous concerns centered significantly on direct-to-consumer telemedicine platforms, where virtual urgent care settings reportedly showed higher rates of unnecessary antibiotic prescriptions. However, this new research distinguishes telehealth visits integrated directly within primary care practices as a separate and more effective model, demonstrating that antibiotics are prescribed in alignment with established clinical guidelines.

The data revealed that while telehealth accounted for a small percentage (2.3%) of all ARTI episodes, those visits resulted in a 16.3% antibiotic prescription rate, markedly lower than the 46.9% observed in-person. This discrepancy is attributable, in part, to the lower frequency of bacterial diagnoses made during telehealth appointments. For instance, acute otitis media, streptococcal pharyngitis, and sinusitis diagnoses were substantially less common in telehealth compared to in-person visits. Despite this, the rates of guideline-concordant antibiotic management were higher in telehealth visits—90.0% versus 85.9%—indicating more stringent adherence to protocols when prescribing antibiotics remotely.

Beyond prescription rates, the study also assessed patient outcomes post-initial visit. Interestingly, although children seen via telehealth had slightly higher follow-up visit rates within the subsequent two weeks, they did not receive significantly more antibiotic prescriptions during this period. This suggests that telehealth does not simply delay or defer antibiotic treatment but rather supports effective initial clinical decision-making, reducing unnecessary antibiotic use without adversely affecting patient health trajectory.

Dr. Samuel Wittman, MS, research data analyst at the University of Pittsburgh and presenting author, emphasized the practical implications of integrating telemedicine into pediatric primary care. "These findings show that when used in the context of a primary care practice, telehealth can allow primary care physicians to provide treatment that aligns with guidelines," Wittman explained. He highlighted that telehealth offers enhanced accessibility, particularly benefiting families facing transportation, financial, or time constraints, thereby democratizing access to appropriate pediatric care.

Methodologically, the study employed a robust logistic regression model with patient-level random intercepts to account for variation across practice sites and patient demographics. The researchers excluded well visits and cases with comorbid conditions warranting antibiotics to focus precisely on ARTI management. This rigorous approach ensured that comparisons between telehealth and in-person visits reflected true differences in prescribing behavior unaffected by extraneous factors.

This research arrives amid a broader shift driven by the COVID-19 pandemic, which catalyzed widespread telemedicine adoption across healthcare sectors. Many primary care practices have since integrated telehealth with in-person care, challenging physicians to maintain quality standards remotely. The study’s findings underscore that, contrary to earlier apprehensions, telehealth integrated within established primary care medical homes supports responsible antibiotic use rather than compromising it.

The implications extend beyond pediatrics, highlighting telemedicine’s potential role in combating antimicrobial resistance globally by reinforcing rational antibiotic prescribing practices. As antibiotic stewardship becomes an urgent public health imperative, these findings advocate for expanding telemedicine infrastructure coupled with clinical oversight to optimize healthcare delivery without sacrificing safety or efficacy.

Additionally, the study’s wide geographic scope and inclusion of diverse patient populations—48.3% insured via Medicaid and 10.8% from Spanish-speaking families—enhance the generalizability of results. This diversity underscores telehealth’s promise as an equitable tool in reducing healthcare disparities, enabling vulnerable communities to receive evidence-based care.

The data and conclusions further dispel the misconception that virtual care necessarily leads to overtreatment or reduced care quality. By systematically analyzing over half a million episodes of pediatric respiratory infections, the research provides a compelling counter-narrative, positioning telehealth as a critical component of modern, integrated primary care models.

In sum, this study elevates the discourse on pediatric telemedicine by presenting empirical evidence that telehealth, when embedded within primary care systems, fosters judicious antibiotic prescribing practices aligned with clinical guidelines. The research advocates for ongoing investments in telehealth infrastructure and provider training to harness its full potential in enhancing pediatric healthcare outcomes while addressing public health challenges like antibiotic resistance.

As health systems worldwide grapple with balancing accessibility, quality, and cost-effectiveness, this work offers a timely exemplar of how thoughtful integration of telemedicine not only maintains but potentially enhances antibiotic stewardship. The forthcoming presentation by Samuel Wittman at the PAS Meeting will undoubtedly stimulate informed discussions by clinicians, researchers, and policymakers striving for evidence-based innovation in child and adolescent health.

Subject of Research: Antibiotic prescribing patterns during telemedicine versus in-person primary care visits for pediatric acute respiratory tract infections.

Article Title: Antibiotic Receipt During Primary Care Telemedicine Versus In-Person Visits for Pediatric Acute Respiratory Tract Infections, 2023.

News Publication Date: Not specified (scheduled presentation in April 2025).

Web References:

• Pediatric Academic Societies Meeting: www.pas-meeting.org
• PAS Meeting Twitter: https://x.com/PASMeeting
• PAS Meeting Facebook: https://www.facebook.com/PASMeeting/

Keywords: Pediatrics, Acute Respiratory Tract Infections, Telemedicine, Antibiotic Stewardship, Antimicrobial Resistance, Primary Care, Pediatric Infectious Diseases, Healthcare Accessibility, Clinical Guidelines, Health Disparities, COVID-19 Pandemic, Electronic Health Records.